Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
3.
Rehabilitación (Madr., Ed. impr.) ; 56(2): 150-158, Abril - Junio, 2022. tab, graf, ilus
Article in Spanish | IBECS | ID: ibc-204903

ABSTRACT

El linfedema es una enfermedad crónica con una elevada incidencia en nuestra sociedad. En este trabajo presentamos una revisión bibliográfica con los últimos avances en técnicas de imagen y tratamiento quirúrgico con técnicas reconstructivas del linfedema (anastomosis linfático-venosas, trasplante vascularizado de ganglios linfáticos y cirugía profiláctica del linfedema). Además, se establece un protocolo basado en el trabajo de un equipo multidisciplinar (compuesto por rehabilitadores, cirujanos plásticos, radiólogos y médicos nucleares) que optimiza el tratamiento de estos pacientes.(AU)


Lymphedema is a chronic disease with a high incidence in our society. In this paper, we present a review with the latest advances in imaging techniques and surgical reconstructive treatment of lymphedema (lymphovenous anastomosis, vascularized lymph node transfer, and prophylactic lymphedema surgery). In addition, a protocol is established based on a multidisciplinary team (composed of physiatrists, plastic surgeons, radiologists and nuclear medicine radiologists) to optimize the treatment of these patients.(AU)


Subject(s)
Interdisciplinary Research , Lymphedema , Microsurgery , Lymphedema/complications , Lymphedema/diagnosis , Chronic Disease , Lymph Nodes/transplantation , Lymphedema/surgery , Manual Lymphatic Drainage , Rehabilitation , Databases, Bibliographic , Pain Management
4.
Rehabilitacion (Madr) ; 56(2): 150-158, 2022.
Article in Spanish | MEDLINE | ID: mdl-34538653

ABSTRACT

Lymphedema is a chronic disease with a high incidence in our society. In this paper, we present a review with the latest advances in imaging techniques and surgical reconstructive treatment of lymphedema (lymphovenous anastomosis, vascularized lymph node transfer, and prophylactic lymphedema surgery). In addition, a protocol is established based on a multidisciplinary team (composed of physiatrists, plastic surgeons, radiologists and nuclear medicine radiologists) to optimize the treatment of these patients.


Subject(s)
Lymphedema , Microsurgery , Humans , Lymphedema/surgery , Microsurgery/methods
6.
Rev. esp. med. nucl. imagen mol. (Ed. impr.) ; 39(6): 347-352, nov.-dic. 2020. ilus, tab
Article in Spanish | IBECS | ID: ibc-202216

ABSTRACT

OBJETIVO: La infección de las prótesis vasculares es una complicación temible por su alta morbimortalidad, en la que el diagnóstico precoz es imprescindible. Evaluamos la utilidad de la gammagrafía con leucocitos marcados con 99mTc-HMPAO y SPECT/TC (GLM-SPECT/TC) en el diagnóstico de esta patología. MATERIALES Y MÉTODOS: Analizamos retrospectivamente 30 GLM-SPECT/TC realizadas en pacientes con sospecha de infección de prótesis vasculares. Se consideró como resultado positivo la captación del radiofármaco en el área protésica con una intensidad superior a la del hígado o la médula ósea de raquis y pelvis. RESULTADOS: El diagnóstico final de infección, basado en los criterios de Fitzgerald, se estableció en 10pacientes, siendo la gammagrafía positiva en 11. No se obtuvieron falsos negativos. Los valores de sensibilidad y especificidad fueron 100% y 95%, respectivamente, con un VPP del 91% y un VPN del 100%. Veinticinco pacientes contaban también con un TC previo a la gammagrafía, que en 9 de los casos fue positivo (4FP). Los resultados de sensibilidad y especificidad del TC fueron del 62,5% y del 76%, con un VPP del 55,6% y un VPN del 81,3%. El diagnóstico de infección conllevó la exéresis del material protésico en 8 casos (todos ellos con confirmación microbiológica), mientras que los 2 restantes fueron tratados únicamente con antibioterapia debido a un alto riesgo quirúrgico. CONCLUSIONES: La GLM-SPECT/TC es una prueba de gran utilidad que presenta una alta precisión diagnóstica en la sospecha de infección de prótesis vasculares


AIM: Vascular graft infection is a rare complication with a high morbidity and mortality. Early diagnosis is essential to establish an adequate treatment. We assess the accuracy of 99mTc-WBC scintigraphy with SPECT/CT in the diagnosis of vascular graft infection. MATERIALS AND METHODS: We retrospectively analyzed thirty 99mTc-WBC scintigraphies with SPECT/CT performed in thirty patients with suspicion of vascular prosthesis infection. Studies were considered positive for graft infection if the intensity of activity involving the graft was greater than the liver or bone marrow activity (spine and pelvis). RESULTS: Final diagnosis of infection was established in 10 patients, based on Fitzgerald criteria. Scintigraphy was positive in 11 patients. No false negatives were obtained. The values of sensitivity and specificity were 100% and 95%, respectively, with a PPV of 91% and a NPV of 100%. Twenty five patients had a CT performed prior to scintigraphy, in 9 cases the result was positive and in the remaining 16 was negative. CT sensitivity and specificity obtained in our study were 62.5% and 76% respectively, with a PPV of 55.6% and a NPV of 81.3%. Diagnosis of infection led to prosthesis exeresis in 8 cases (all of them had a positive microbiological study of the extracted material), while the remaining 2 patients were treated with antibiotic therapy alone due to high surgical risk. CONCLUSION: Our results suggest a high accuracy for 99mTc-WBC scintigraphy with SPECT/CT in the assessment of clinically suspected arterial graft infection


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Tomography, Emission-Computed, Single-Photon , Prosthesis-Related Infections/diagnostic imaging , Blood Vessel Prosthesis/microbiology , Radionuclide Imaging/methods , Leukocytes , Retrospective Studies
7.
Article in English, Spanish | MEDLINE | ID: mdl-32616455

ABSTRACT

AIM: Vascular graft infection is a rare complication with a high morbidity and mortality. Early diagnosis is essential to establish an adequate treatment. We assess the accuracy of 99mTc-WBC scintigraphy with SPECT/CT in the diagnosis of vascular graft infection. MATERIALS AND METHODS: We retrospectively analyzed thirty 99mTc-WBC scintigraphies with SPECT/CT performed in thirty patients with suspicion of vascular prosthesis infection. Studies were considered positive for graft infection if the intensity of activity involving the graft was greater than the liver or bone marrow activity (spine and pelvis). RESULTS: Final diagnosis of infection was established in 10 patients, based on Fitzgerald criteria. Scintigraphy was positive in 11 patients. No false negatives were obtained. The values of sensitivity and specificity were 100% and 95%, respectively, with a PPV of 91% and a NPV of 100%. Twenty five patients had a CT performed prior to scintigraphy, in 9 cases the result was positive and in the remaining 16 was negative. CT sensitivity and specificity obtained in our study were 62.5% and 76% respectively, with a PPV of 55.6% and a NPV of 81.3%. Diagnosis of infection led to prosthesis exeresis in 8 cases (all of them had a positive microbiological study of the extracted material), while the remaining 2 patients were treated with antibiotic therapy alone due to high surgical risk. CONCLUSION: Our results suggest a high accuracy for 99mTc-WBC scintigraphy with SPECT/CT in the assessment of clinically suspected arterial graft infection.


Subject(s)
Blood Vessel Prosthesis/adverse effects , Leukocytes , Prosthesis-Related Infections/diagnostic imaging , Radionuclide Imaging/methods , Radiopharmaceuticals , Single Photon Emission Computed Tomography Computed Tomography/methods , Technetium Tc 99m Exametazime , Vascular Grafting , Vasculitis/diagnostic imaging , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Blood Vessel Prosthesis/microbiology , Device Removal , False Negative Reactions , False Positive Reactions , Female , Humans , Image Processing, Computer-Assisted , Male , Middle Aged , Prosthesis-Related Infections/microbiology , Retrospective Studies , Sensitivity and Specificity , Tomography, X-Ray Computed , Vasculitis/microbiology
8.
Int J Cardiol Heart Vasc ; 7: 131-140, 2015 Jun 01.
Article in English | MEDLINE | ID: mdl-28785661

ABSTRACT

The main objective of this study was to create a postnatal model for cardiac hypertrophy (CH), in order to explain the mechanisms that are present in childhood cardiac hypertrophy. Five days after implantation, intraperitoneal (IP) isoproterenol (ISO) was injected for 7 days to pregnant female mice. The fetuses were obtained at 15, 17 and 19 dpc from both groups, also newborns (NB), neonates (7-15 days) and young adults (6 weeks of age). Histopathological exams were done on the hearts. Immunohistochemistry and western blot demonstrated GATA4 and PCNA protein expression, qPCR real time the mRNA of adrenergic receptors (α-AR and ß-AR), alpha and beta myosins (α-MHC, ß-MHC) and GATA4. After the administration of ISO, there was no change in the number of offsprings. We observed significant structural changes in the size of the offspring hearts. Morphometric analysis revealed an increase in the size of the left ventricular wall and interventricular septum (IVS). Histopathological analysis demonstrated loss of cellular compaction and presence of left ventricular small fibrous foci after birth. Adrenergic receptors might be responsible for changing a physiological into a pathological hypertrophy. However GATA4 seemed to be the determining factor in the pathology. A new animal model was established for the study of pathologic CH in early postnatal stages.

9.
Rev. esp. med. nucl. imagen mol. (Ed. impr.) ; 31(6): 335-337, nov.-dic. 2012. ilus
Article in Spanish | IBECS | ID: ibc-105650

ABSTRACT

Mujer de 53 años diagnosticada de cáncer colorrectal, quien recibió tratamiento quirúrgico y quimioterápico, tras 5 años de remisión completa presenta una evolución atípica de su patología oncológica. La utilidad de la PET/TAC con 18F-FDG ha sido fundamental para la detección de las recidivas, sospechadas y no sospechadas, y para la monitorización de la respuesta al tratamiento(AU)


A 53-year-old woman with diagnosis of colorectal cancer, who received surgical treatment and chemotherapy. After 5-years of complete remission, she showed an atypical oncological evolution. The utility of 18F-FDG PET/CT scan has been fundamental to detect suspected and unsuspected recurrence and to monitor response to treatment(AU)


Subject(s)
Humans , Female , Middle Aged , Fluorodeoxyglucose F18/therapeutic use , Colorectal Neoplasms/diagnosis , Neoplasm Metastasis , Chemotherapy, Adjuvant , /methods , Positron Emission Tomography Computed Tomography/methods , Positron Emission Tomography Computed Tomography , Colorectal Neoplasms/physiopathology , Colorectal Neoplasms , Radiography, Thoracic , Biomarkers, Tumor/administration & dosage , Nuclear Medicine/methods , Positron Emission Tomography Computed Tomography/instrumentation , Positron Emission Tomography Computed Tomography/trends
11.
Rev. esp. med. nucl. (Ed. impr.) ; 29(2): 57-62, mar.-abr. 2010. tab, ilus
Article in Spanish | IBECS | ID: ibc-78293

ABSTRACT

ObjetivoRealizar un análisis descriptivo de la implicación clínico-diagnóstica de la exploración con 123I-Iodobenzamida (IBZM) en los pacientes estudiados en nuestro centro por trastornos del movimiento sugerentes de Parkinson plus (PP).Material y métodoSe realizó SPECT con 123I-IBZM a 46 pacientes, procedentes de la consulta de trastornos del movimiento, por sospecha de PP. Según la clínica se distribuyeron en 3 grupos: 35 pacientes presentaban clínica atípica (CA) para enfermedad de Parkinson, 2 mostraban falta de respuesta al tratamiento habitual (FR) y en 9 se presentaban ambos factores (CA y FR). El resultado del SPECT se valoró únicamente de forma cualitativa.ResultadosDe los 35 pacientes con CA el 123I-IBZM apoyó el diagnóstico de PP en 15(42,9%), de los 2 con FR el estudio fue patológico en 1 y, de los 9 que presentaban ambos factores (CA y FR), el 123I-IBZM fue patológico en 6 casos (66,7%).ResultadosEn el 95,7% de la muestra (44 pacientes) la CA, con o sin FR, era el principal factor de sospecha de PP, y sólo en el 47,7% (22 pacientes) el 123I-IBZM resultó alterado. De estos 22 casos, en 20 el diagnóstico definitivo fue de PP (elevado valor predictivo positivo).ConclusiónEl estudio con 123I-IBZM es de gran utilidad en la práctica clínica, al proporcionar una información diagnóstica objetiva con implicaciones en el tratamiento y pronóstico de los pacientes con sospecha de PP(AU)


ObjectiveTo perform a descriptive analysis of the clinical and diagnostic implications of 123I-IBZM SPECT in the patients studied in our center for movement disorders suggestive of Parkinson-Plus Disease (PP).Subjects and methods123I-IBZM SPECT was performed in 46 patients referred from the movement disorders consultation due to suspicion of PP. According to their symptoms, they were distributed into 3 groups: 35 patients had atypical symptoms (AS) for Parkinson's Disease, 2 showed no response to standard therapy (NR) and 9 presented both factors (AS, NR). The results of SPECT were only assessed qualitatively.ResultsThe 123I-IBZM supported the diagnosis of PP in 15(42.9%) out of the 35 patients with AS. The 123I-IBZM was pathological in one of the two NR patients. Regarding the third group of patients (AS+NR), the 123I-IBZM was pathological in 6 cases (66.7%).ResultsIn 95.7% of our sample (44 patients), AS with or without NR was the main factor leading to suspicion of PP and the 123I-IBZM was altered in only 47.7% (22 patients). Of these 22 cases, the final diagnosis was PP (with high positive predictive value) in 20(91%).ConclusionThe study with 123I-IBZM is useful in the clinical practice because it provides objective diagnostic information with implications for the treatment and prognosis of patients with suspicion of PP(AU)


Subject(s)
Humans , Male , Female , Middle Aged , Diagnosis, Differential , Iodine Compounds/administration & dosage , Iodine Compounds/therapeutic use , Iofetamine/therapeutic use , Parkinson Disease/diagnosis , Parkinson Disease/drug therapy , Tomography, Emission-Computed, Single-Photon/methods , Predictive Value of Tests , Parkinson Disease/physiopathology , Parkinson Disease , Nuclear Medicine/methods , Receptors, Dopamine/administration & dosage , Dopamine Antagonists
12.
Rev Esp Med Nucl ; 29(2): 57-62, 2010.
Article in Spanish | MEDLINE | ID: mdl-20133020

ABSTRACT

OBJECTIVE: To perform a descriptive analysis of the clinical and diagnostic implications of (123)I-IBZM SPECT in the patients studied in our center for movement disorders suggestive of Parkinson-Plus Disease (PP). SUBJECTS AND METHODS: (123)I-IBZM SPECT was performed in 46 patients referred from the movement disorders consultation due to suspicion of PP. According to their symptoms, they were distributed into 3 groups: 35 patients had atypical symptoms (AS) for Parkinson's Disease, 2 showed no response to standard therapy (NR) and 9 presented both factors (AS, NR). The results of SPECT were only assessed qualitatively. RESULTS: The (123)I-IBZM supported the diagnosis of PP in 15(42.9%) out of the 35 patients with AS. The (123)I-IBZM was pathological in one of the two NR patients. Regarding the third group of patients (AS+NR), the (123)I-IBZM was pathological in 6 cases (66.7%). In 95.7% of our sample (44 patients), AS with or without NR was the main factor leading to suspicion of PP and the (123)I-IBZM was altered in only 47.7% (22 patients). Of these 22 cases, the final diagnosis was PP (with high positive predictive value) in 20(91%). CONCLUSION: The study with (123)I-IBZM is useful in the clinical practice because it provides objective diagnostic information with implications for the treatment and prognosis of patients with suspicion of PP.


Subject(s)
Iodine Radioisotopes , Iodobenzenes , Neurodegenerative Diseases/diagnostic imaging , Parkinson Disease/diagnostic imaging , Parkinsonian Disorders/diagnostic imaging , Radiopharmaceuticals , Tomography, Emission-Computed, Single-Photon , Adult , Aged , Brain/diagnostic imaging , Corpus Striatum/diagnostic imaging , Diagnosis, Differential , Female , Humans , Iodine Radioisotopes/pharmacokinetics , Iodobenzenes/pharmacokinetics , Male , Middle Aged , Movement Disorders/diagnostic imaging , Predictive Value of Tests , Radiopharmaceuticals/pharmacokinetics , Receptors, Dopamine D2/analysis
13.
Clin. transl. oncol. (Print) ; 11(8): 493-498, ago. 2009. ilus
Article in English | IBECS | ID: ibc-123666

ABSTRACT

Gastric cancer is a leading cause of death worldwide. Nowadays, complete surgical resection and TNM at diagnosis are the main prognostic factors. In spite of this, many patients will have a recurrence after surgery and die within a few months or years. That means that we need more accurate prognostic factors to design specific approaches for individual patients. Chromosome instability is a feature of gastric cancer commonly associated to chromosomal aberrations that leads to major modifications of DNA content globally termed as aneuploidy. In this regard, many authors' opinions diverge regarding the clinical impact of aneuploidy. This review will summarise data on the clinical impact of aneuploidy on clinical practice, the biological mechanisms that underlie chromosomal instability that induces aneuploidy and the relevance of specific chromosomal aneuploidy to cancer biology (AU)


Subject(s)
Humans , Animals , Male , Female , Aneuploidy , Stomach Neoplasms/diagnosis , Stomach Neoplasms/genetics , Stomach Neoplasms/pathology , Centrosome/metabolism , Prognosis
14.
Clin. transl. oncol. (Print) ; 10(11): 753-757, nov. 2008. tab, ilus
Article in English | IBECS | ID: ibc-123550

ABSTRACT

PURPOSE: Fatigue is a cancer-related symptom with great impact on patients' daily lives, but often not discussed with their oncologists. This survey explored functional and psychological fatigue impact among different cancer symptoms according to patient's perception (pp). METHODS: A cross-sectional, self-administered survey was conducted in 10 oncologist services throughout Spain. Demographical data and tumour diagnoses were collected. Fatigue impact on functional and social activities (Likert scale) and on emotional well-being (visual analogue scale) was measured. The pp of oncologist's response to fatigue report was recorded. RESULTS: 505 surveyed cancer patients were analysed (55.2% women, aged 58.8 years +/-11.7), 97.8% remembered experiencing fatigue during treatment. 27.1% did not discuss their fatigue with their oncologist. Fatigue affected patient's daily routine (> or = 50% of times) included self-care (58.26%), entertainment activities (69.8%), and relationships (71.4%). Fatigue was the most bothersome symptom of cancer. CONCLUSIONS: Cancer patients perceive fatigue as the symptom with highest impact on their daily living and that substantially affects their emotional and social areas (AU)


No disponible


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Activities of Daily Living , Fatigue/psychology , Fatigue/etiology , Leisure Activities/psychology , Neoplasms/psychology , Patients/psychology , Cross-Sectional Studies/methods , Emotions , Fatigue/therapy , Neoplasms/complications , Physician-Patient Relations , Quality of Life , Social Isolation , Treatment Outcome , Self Care , Health Surveys
SELECTION OF CITATIONS
SEARCH DETAIL
...